Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus

Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus

Abstract Background Nonconvulsive status epilepticus (NCSE) is a diagnosis that is often challenging and one that may progress to refractory NCSE. Ketamine is a noncompetitive N-methyl-d-aspartate antagonist that increasingly has been used to treat refractory status epilepticus. Current Neurocritica...

Full description

Bibliographic Details
Main Authors: Michael A. Pizzi, Prasuna Kamireddi, William O. Tatum, Jerry J. Shih, Daniel A. Jackson, William D. Freeman
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Journal of Intensive Care
Subjects:
Enteral ketamine
Intravenous ketamine
Nonconvulsive status epilepticus
Refractory status epilepticus
Seizures
Online Access:http://link.springer.com/article/10.1186/s40560-017-0248-6

Internet

http://link.springer.com/article/10.1186/s40560-017-0248-6

Similar Items